shafi_banner

Labaran Kamfani

  • An gano Kit ɗin Gano Ciwon Ciwon Urothelial ...

    Farkon Mayu 2023, TAGMe DNA Methylation Kit (qPCR) don Ciwon Urothelial Cancer wanda Shanghai Epiprobe Biotechnology Co., Ltd ya haɓaka da kansa, ya sami "Nazarin Na'urar Na'ura" daga FDA ta Amurka.US FDA Breakthrough Devices Programme na nufin tabbatar da inganta…
    Kara karantawa
  • TAGMe DNA Methylation Kits (qPCR) don...

    Magani ga ciwon daji na endometrial, kawar da ciwon daji a mataki na precancerous raunuka.Ciwon daji na endometrial yana ɗaya daga cikin manyan cututtukan daji guda uku a cikin ilimin mata.Ciwon daji na endometrial yana daya daga cikin cututtukan daji mafi yawa a cikin tsarin haihuwa na mace, ranki ...
    Kara karantawa
  • Kiwon Lafiyar Baidu da Epiprobe tare da haɗin gwiwar ci gaba da aiwatar da fara gwajin cutar sankara

    Kiwon Lafiyar Baidu da Epiprobe sun haɗu tare…

    Oktoba 30, 2022, asibitin Intanet na Lafiya na Baidu (wanda ake kira "Baidu Health") da Shanghai Epiprobe Biotechnology Co., Ltd. (wanda ake kira "Epiprobe") sun ba da sanarwar haɗin gwiwar dabarun don yada farkon gwajin cutar kansa a cikin asibiti da na gaba ɗaya. tashar lafiya duri...
    Kara karantawa
  • Kayan aikin gano cutar kansa guda uku na Epiprobe sun sami takardar shedar CE ta EU

    Epiprobe ta uku ciwon daji methylation gano k...

    A ranar 8 ga Mayu, 2022, Epiprobe ta ba da sanarwar cewa ta keɓance kayan aikin gano ƙwayoyin cutar kansa guda uku: TAGMe DNA Methylation Detection Kits (qPCR) don Ciwon Sankara na Cervical, TAGMe DNA Methylation Detection Kits (qPCR) don Ƙarshe ...
    Kara karantawa
  • Epiprobe ya kammala kusan RMB miliyan 100 na tallafin Series B

    Epiprobe ya kammala kusan RMB miliyan 100 na Se...

    A baya-bayan nan, Shanghai Epiprobe Biotechnology Co., Ltd. (ana nufin "Epiprobe") ya sanar da cewa ya kammala kusan RMB miliyan 100 a cikin tallafin Series B, wanda babban birnin masana'antu, dandamalin saka hannun jari na gwamnati ...
    Kara karantawa